×

Navigate to:

US-NIH names DLSMHSI a research site for the ACTG

April 12, 2021 | 8:40 am

De La Salle Medical and Health Sciences Institute’s Centers for Health Research has been selected by the National Institutes of Health (NIH) in the United States as one of 101 clinical research sites (CRSs) responsible for implementing the scientific agenda of the NIH HIV/AIDS clinical research networks. The CRSs are funded by NIH’s National Institute of Allergy and Infectious Diseases (NIAID). The site will be under the umbrella of Emory HIV Clinical Trials Unit (CTU) in Atlanta, Georgia which was one of the 35 CTUs selected for this recompetition. The seven-year award to Emory has an expected funding of $12.5 million.

 

As a CRS, DLSMHSI will conduct clinical trials within The AIDS Clinical Trials Group (ACTG). The DLSMHSI CRS is directed by Dr. Melchor Frias, a professor in Pediatrics of the DLSMHSI College of Medicine and a clinical epidemiologist; and Dr. Maria Tarcela Gler, an Infectious Disease Specialist and an MDR-TB clinician.

 

This distinction is a continuation of DLSMHSI’s involvement in US-NIH funded clinical trials and studies after DLSMHSI was identified as a protocol-specific site for the AIDS Clinical Trials Group (ACTG) and International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) networks’ Phase 3 international multicenter trial entitled “Protecting Households On Exposure to Newly Diagnosed Index Multidrug-resistant Tuberculosis Patients (PHOENIX)” which commenced in November 2016.

 

The research activities of the NIH HIV clinical trials networks also include the treatment and prevention of other infectious diseases, including tuberculosis and hepatitis, which are the most significant co-infections for people living with, or at risk for, HIV.

 

The Emory HIV CTU is directed by two principal investigators, Dr. Jeffrey Lennox, professor of medicine in infectious diseases and associate dean for clinical research at Emory University School of Medicine; and Dr. Carlos del Rio, professor of medicine in infectious diseases and executive associate dean for Emory School of Medicine at Grady Health System and co-director of the Emory Center for AIDS Research.

 

“We are very excited about the important clinical trials work this grant will continue to allow us to pursue,” says Lennox at the announcement of the grant for new funding.
“Our existing Emory CTU has been very successful in conducting HIV clinical trials, but our partnerships in Mexico and the Philippines expand our reach to two key international sites and will allow us to move forward with new research that could make a significant impact on this still challenging disease,” says del Rio.

 

More information about the NIH HIV Clinical Trials Networks can be accessed at
https://www.niaid.nih.gov/research/hiv-research-enterprise.

Top News

DLSMHSI welcomes Professor Dr. Charles Robert Horsburgh from Boston University, School of Public Health, Department of Epidemiology, Biostatistics, Global Health and Medicine, United States of America, on January 9, 2023.

February 1, 2023 | 9:58 am

Archbishop of Lipa bestows Episcopal Blessing on DLSUMC for its “enormous contributions during the pandemic.”

January 5, 2023 | 1:07 pm

DLSMHSI collaborates with UK’s InHealth Ltd for scholarship to employment initiatives

November 28, 2022 | 1:15 pm

Exploring indirect impacts of COVID-19 on local health systems from the perspectives of health workers and higher education stakeholders in the Philippines using a phenomenological approach

September 21, 2022 | 4:41 pm

Br. Gus joins over 100 education leaders in supporting the Leni Robredo and Kiko Pangilinan tandem

March 8, 2022 | 10:40 am